跳至主要内容
临床试验/DRKS00016742
DRKS00016742已完成未知

Clinical Investigation of the Bacterially-Derived Healon Ophthalmic Viscosurgical Device (OVD) - VSCO-201-HLNP

Johnson and Johnson Vision0 个研究点目标入组 139 人开始时间: 2019年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
139

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Cataract for which extraction and posterior IOL implantation have been planned for one or both eyes
  • Clear intraocular media, other than cataract
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent

排除标准

  • Pupil abnormalities
  • Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject
  • Known steroid responder
  • Ocular hypertension , medically-controlled ocular hypertension , or glaucomatous changes in the optic nerve
  • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
  • Concurrent participation, or participation within 45 days prior to the preoperative visit, in any other clinical trial

研究者

发起方
Johnson and Johnson Vision

相似试验